Cerebras prices IPO above range, raising $5.55B

Cerebras walked its marketed share-price range up the elevator twice in roughly a week. The original S-1 amendment carried a $115-$125 band; CNBC reported the company widened to a $150-$160 range after the book ran more than 20 times oversubscribed ^[11]; the final pricing settled at $185 — above even that revised top ^[1]. The math on demand is striking: 30 million Class A shares at $185 raises $5.55B for the company itself, and a 4.5M-share greenshoe (15%) sits on top ^[1]. Per Dealogic, that makes CBRS the largest stock-market debut globally so far in 2026 ^[2].

The order-book frenzy reflects two scarcity dynamics at once: a small floating share count relative to demand for any pure-play AI-chip exposure, and the inability of generalist investors to fill an AI-infrastructure allocation through Nvidia alone. The result is a price reset that condensed roughly nine months of private-market repricing — from a $23B valuation in February to $56.4B fully diluted at the IPO — into a single day of bookbuilding ^[5]. Wall Street is reading the print as a green light for the rest of the 2026 AI IPO pipeline ^[5].

The valuation trajectory is the most consequential single fact in the prospectus. Cerebras moved from a roughly $8.1B private valuation in September 2025, to a $23B funding round in February 2026, to a $56.4B fully diluted IPO mark on May 13 — Morningstar's Brian Colello flagged the jump as 'remarkable' even by AI-cycle standards ^[5]. The $5.55B raise gives the company a war chest large enough to fund the 250 megawatts of OpenAI compute Cerebras has committed to stand up by year end ^[4], and to widen its TSMC wafer commitments for WSE-3.

But it also imports significant valuation gravity. Against 2025 revenue of $510M, the $56.4B fully diluted mark sits at a steep multiple of trailing sales — versus Nvidia at ~25x, Broadcom at ~29x and AMD at ~19x ^[4]. The 'growth-into-multiple' bar is therefore very high — Cerebras needs to convert its $24.6B revenue backlog ^[4]into ratable revenue at gross margins that approach merchant-silicon peers, while the buy side absorbs an inevitably large lockup expiry six months out.

Read past the headline customer count and the revenue base looks narrow. In 2025, MBZUAI contributed 62% of Cerebras' $510M in revenue and G42 contributed 24% — meaning 86% of last year's top line came from two UAE-affiliated entities ^[8]. That is what Futurum Group is gesturing at when it says 'it's not as clean as some of these other AI infrastructure companies' ^[5].

The 2026 picture changes shape rather than diversifies. The $24.6B backlog disclosed at year-end 2025 is dominated by OpenAI's roughly $20B / 750MW commitment ^[4], with AWS planning to deploy Cerebras alongside its in-house Trainium chips ^[4]. In other words, customer concentration is migrating from UAE-linked sovereign-AI buyers to US hyperscaler/AI-lab anchors — but at no point does any 12-month window have more than a handful of names underwriting the print. That makes Cerebras' top line much more sensitive than Nvidia's to the capex decisions of any single anchor; a deferred phase of the OpenAI buildout or a softer UAE follow-on would land directly in the P&L. On Reddit's r/stocks, the most-upvoted IPO-week post explicitly cited the 86% UAE concentration plus a peer-relative valuation gap as reasons to pass at $160 — a community read that turns out to have been more durable than the bankers' second range raise.

OpenAI is simultaneously Cerebras' largest commercial customer and one of its most consequential capital-structure stakeholders — a configuration almost no other recently public chip company has had to underwrite. In December 2025, OpenAI loaned Cerebras $1B secured by warrants for over 33 million shares, with TechCrunch reporting that the structure could leave OpenAI owning up to roughly 10% of Cerebras over time ^[6]. The commercial side is a multi-year deal worth ~$20B to rent 750MW of capacity from 2026-2028, against which The Motley Fool flags a hard near-term milestone: Cerebras 'will have to stand up 250 megawatts of computing capacity for OpenAI by year end' ^[4].

That deadline is the single largest execution-risk item in the prospectus. It requires Cerebras to push WSE-3 systems through TSMC's N5 capacity on a tight schedule while simultaneously building or leasing data-center power. The cap-table angle is just as important: warrant exercise would meaningfully dilute Class B holders, and OpenAI's growing equity overhang means CBRS' trading price becomes partially a function of OpenAI's own evolving capital plans. The angel-investor optics — Sam Altman, Greg Brockman and Ilya Sutskever all hold personal positions ^[6]— sharpen rather than soften that dependence.

Underneath the financial pyrotechnics is a specific technical thesis: AI workloads are rotating from training to inference, and that rotation favors wafer-scale design. PitchBook's Dimitri Zabelin frames the macro — 'the AI hardware market rotated from training-cycle dominance toward inference-cycle scaling' ^[7]. Cerebras' WSE-3, unveiled in March 2024 on TSMC 5nm with 4 trillion transistors and 900,000 AI-optimized cores ^[10], is designed exactly for the high-throughput, low-latency token-serving regime that inference workloads demand — a single wafer collapses what would otherwise be hundreds of GPU-to-GPU interconnect hops into on-die SRAM and fabric.

Morningstar argues Cerebras 'sits in a sweet spot for the current phase of the AI boom' ^[5]. The risk on the technical side is supply-chain rather than performance: WSE-3 'notably uses TSMC's N5 process for its wafer-scale chips...creating significant supply chain risk' ^[4], leaving Cerebras with a single foundry partner for a process node the entire AI accelerator industry is bidding for. If TSMC capacity is the binding constraint on the OpenAI buildout, the equity story decouples from any product-quality argument and becomes a question of allocation.